What's Happening?
A review of the latest trial evidence, published by The BMJ, indicates that extracorporeal shockwave therapy (ESWT) likely reduces short-term pain associated with frozen shoulder. ESWT involves delivering low-energy sound waves to damaged tissue to stimulate
blood flow and healing. The review, which analyzed 189 randomized controlled trials involving 12,988 adults with adhesive capsulitis (frozen shoulder), found moderate-certainty evidence for short-term pain reduction compared to usual care. While there were indications that ESWT might also improve short-term function, flexion, and abduction, these benefits are considered less certain due to low-certainty evidence and inconsistent data. The review also noted that manipulation under anesthesia, with or without steroid injections, probably improved short-term flexion.
Why It's Important?
This review provides valuable insights for healthcare providers and patients in the U.S. grappling with frozen shoulder, a condition common among individuals aged 40-60. The finding that ESWT can offer short-term pain relief provides a potential non-invasive treatment option, which could reduce reliance on more aggressive interventions or long-term pain medication. However, the uncertainty regarding lasting benefits and comparative safety underscores the need for continued research. For the medical device industry, this highlights the ongoing relevance of shockwave therapy technologies, while also signaling areas where further clinical trials are needed to establish long-term efficacy and safety profiles. This information is crucial for informing evidence-based treatment decisions and patient expectations.
What's Next?
The researchers emphasize that most other treatment effects, particularly beyond three months and concerning comparative safety, remain uncertain due to low-certainty evidence and inconsistent reporting of adverse events. This suggests a critical need for more robust, long-term studies to fully understand the benefits and risks of ESWT and other treatments for frozen shoulder. Future research should focus on standardized reporting of outcomes, longer follow-up periods, and comparisons across various treatment modalities. Clinicians are advised to consider invasiveness, costs, patient preferences, and clinical expertise when making treatment decisions, especially within the first six months of the condition, given the current limitations in long-term data.
Beyond the Headlines
The findings from The BMJ review highlight a broader challenge in medical research: the difficulty in establishing definitive long-term efficacy and safety for many treatments, particularly in conditions with varied presentations and responses. The reliance on 'moderate-certainty evidence' for short-term benefits versus 'low-certainty evidence' for other aspects underscores the complexities of clinical trials and meta-analyses. This situation can lead to a landscape where patients and providers must weigh immediate relief against unknown long-term outcomes. It also points to the importance of shared decision-making, where patient values and preferences play a significant role alongside available scientific evidence, especially when the evidence base is incomplete or uncertain.
